Anne Wojcicki pays $305mn to defeat a previous deal struck with Regeneron Pharmaceuticals

Business whose advisers include former MI6 chief and ex-CIA deputy director valued at more than £250mn

Deal would mark latest move by a life sciences group to jettison lower-growth assets

The deal values the data-labelling company at $29bn

Anne Wojcicki to buy back 23andMe and its data for $305 million

Anne Wojcicki pays $305mn to defeat a previous deal struck with Regeneron Pharmaceuticals

Anne Wojcicki made $305m bid for firm, which has lost customers since declaring bankruptcy, with backing of Fortune 500 company